UCL receives Research England grant as part of TenU

UCL, working in partnership with ten of the world's top universities, has been awarded a share of £1.5 million in two grants from The Research England Development (RED) Fund to share and develop improved approaches to commercialising university research for societal and economic benefit, both internationally and in the UK. The grants support two programmes - TenU and a new Policy Evidence Unit for University Commercialisation and Innovation (UCI). The funds for both grants will be administered by the University of Cambridge. UCL is part of TenU, a leading practitioner group, which will use its expertise to develop, improve and share best practice in commercialising research. It brings together the heads of the world's leading technology transfer organisations (TTOs) at ten top universities - Cambridge (UK), Columbia (USA), Edinburgh (UK), Imperial College London (UK), Leuven (Belgium), Manchester (UK), MIT (USA), Oxford (UK), Stanford (USA) - and UCL (UK). The UK Government has identified universities as key drivers of innovation, and university TTOs are playing a significant role in translating research-based innovations into services and products. Research from these universities has led to many world changing innovations - including UCL's rapid programmed T cell therapies which has seen scientists at UCL identifying how a discovery in immune cells holds the key to powerful therapies against cancer.